Current importance of sublingual immuotherapy in allergic diseases;Aktueller stellenwert der sublingualen immuntherapie bei allergischen krankheiten

Allergologie

Volumn 27, Issue 9, 2004, Pages 381-384

  Kleine Tebbe, J ^a   Bergmann, K C ^b   Bufe, A ^b   Friedrichs, F ^b   Fuchs, Th ^b   Hirsch, Th ^b   Klimek, L ^b   Lepp, U ^b   Przybilla, B ^b   Rakoski, J ^b   Rebien, W ^b   Saloga, J ^b   Schultze Werninghaus, G ^b   Virchow, J C ^b  

^a Allergie und Asthma Zentrum Westend   (Germany)

^b NONE

Author keywords

Allergic rhinitis; Assessment; Bronchial asthma; Childhood; Safety; Sublingual immunotherapy

Indexed keywords

ALLERGEN;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ALLERGY; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; REVIEW;

EID: 4644362026     PISSN: 03445062     EISSN: None     Source Type: Journal    
DOI: 10.5414/alp27381     Document Type: Review

References (14)

1. Arzneimittelkommission der deutschen Ärzteschaft: Hyposensibilisierung - Indikationen, Kontraindikationen, unerwünschte Wirkungen. Dtsch. Ärztebl. 94, A330-A331 (1997).
2. Bousquet J., P. Van Cauwenberge, N. Khaltaev: Allergic rhinitis and its impact on asthma. J. Allergy Clin. Immunol. 108, S147-S334 (2001).
3. Bufe A., E. Ziegler-Kirbach, E. Stöckmann, P. Heidemann, K. Gehlhar, T. Holland-Letz, W. Braun: Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 59, 498-504 (2004).
4. Canonica G.W., G. Passalacqua: Noninjection routes for immunotherapy. J. Allergy Clin. Immunol. 111, 437-448 (2003).
5. Durham S.R., S.M. Walker, E.M. Varga, M.R. Jacobson, F. O'Brien, W. Noble, S.J. Till, Q.A. Hamid, K.T. Nouri-Aria: Long-term clinical efficacy of grass pollen immunotherapy. N. Engl. J. Med. 341, 468-475 (1999).
6. Ippoliti F., W. De Santis, A. Volterrani, L. Lenti, N. Canitano, S. Lucarelli, T. Frediani: Immunomodulation during sublingual therapy in allergic children. Pediatr. Allergy Immunol. 14, 216-221 (2003).
7. Khinchi M.S., L.K. Poulsen, F. Carat, C. André, A.B. Hansen, H.J. Mailing: Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study. Allergy 59, 45-53 (2004).
8. La Rosa M., C. Ranno, C. André, F. Carat, M.A. Tosca, C.W. Canonica: Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J. Allergy Clin. Immunol. 104, 425-432 (1999).
9. Lüderitz-Püchel U., B. Keller-Stanislawski, D. Haustein: Neubewertung des Risikos von Testund Therapieallergenen. Eine Analyse der UAW-Meldungen von 1991 bis 2000. Bundesgesundheitsbl. Gesundheitsforsch. Gesundheitsschutz 44, 709-718 (2001).
10. Mailing H.J.: Is sublingual immunotherapy clinically effective? Curr. Opin. Allergy Clin. Immunol. 2, 523-531 (2002).
11. Mailing H.J.: Criteria for clinical efficacy - read-out and monitoring of clinical studies. Arb. Paul Ehrlich Inst. Bundesamt Sera Impfstoffe Frankfurt a.M. 2003, 119-123, discussion 123-125..
12. Pajno G.B., D. Vita, S. Parmiani, L. Caminiti, S. La Grutta, G. Barberio: Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate. Clin. Exp. Allergy 33, 1641-1647 (2003).
13. Rolinck-Werninghaus C., H. Wolf, C. Liebke, J.C. Baars, J. Lange, M.V. Kopp, J. Hammermann, W. Leupold, P. Bartels, A. Grübl, C.P. Bauer, J. Schnitker, U. Wahn, B. Niggemann: A prospective, randomized, double-blind, placebo-controlled multicentre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy, in press (2004).
14. Wilson D.R., M. Torres Lima, S.R. Durham: Sublingual immunotherapy for allergic rhinitis (Cochrane Review). In: The Cochrane Library, Issue 2. Wiley & Sons, Chichester 2004.